鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/10 | 3,090 | 3,135 | 3,090 | 3,115 | ±0 | ±0% | 26,900 |
| 2022/05/09 | 3,175 | 3,180 | 3,085 | 3,115 | -70 | -2.2% | 34,400 |
| 2022/05/06 | 3,170 | 3,210 | 3,145 | 3,185 | +10 | +0.3% | 22,800 |
| 2022/05/02 | 3,060 | 3,190 | 3,050 | 3,175 | -95 | -2.9% | 60,300 |
| 2022/04/28 | 3,195 | 3,270 | 3,170 | 3,270 | +135 | +4.3% | 33,500 |
| 2022/04/27 | 3,150 | 3,175 | 3,110 | 3,135 | -30 | -0.9% | 60,300 |
| 2022/04/26 | 3,145 | 3,180 | 3,140 | 3,165 | +25 | +0.8% | 28,200 |
| 2022/04/25 | 3,160 | 3,190 | 3,135 | 3,140 | -55 | -1.7% | 29,600 |
| 2022/04/22 | 3,165 | 3,210 | 3,145 | 3,195 | +5 | +0.2% | 17,700 |
| 2022/04/21 | 3,210 | 3,215 | 3,175 | 3,190 | -30 | -0.9% | 17,800 |
| 2022/04/20 | 3,150 | 3,240 | 3,150 | 3,220 | +50 | +1.6% | 39,800 |
| 2022/04/19 | 3,135 | 3,175 | 3,130 | 3,170 | +45 | +1.4% | 22,700 |
| 2022/04/18 | 3,100 | 3,135 | 3,080 | 3,125 | +25 | +0.8% | 25,100 |
| 2022/04/15 | 3,120 | 3,120 | 3,075 | 3,100 | -40 | -1.3% | 17,200 |
| 2022/04/14 | 3,130 | 3,150 | 3,125 | 3,140 | +10 | +0.3% | 9,700 |
| 2022/04/13 | 3,095 | 3,130 | 3,080 | 3,130 | +5 | +0.2% | 35,600 |
| 2022/04/12 | 3,105 | 3,165 | 3,105 | 3,125 | -50 | -1.6% | 22,000 |
| 2022/04/11 | 3,170 | 3,185 | 3,140 | 3,175 | -5 | -0.2% | 29,400 |
| 2022/04/08 | 3,185 | 3,195 | 3,140 | 3,180 | +20 | +0.6% | 33,400 |
| 2022/04/07 | 3,095 | 3,175 | 3,075 | 3,160 | +40 | +1.3% | 64,300 |
| 2022/04/06 | 3,150 | 3,150 | 3,090 | 3,120 | -30 | -1% | 22,600 |
| 2022/04/05 | 3,150 | 3,160 | 3,125 | 3,150 | +20 | +0.6% | 20,600 |
| 2022/04/04 | 3,150 | 3,160 | 3,110 | 3,130 | -20 | -0.6% | 22,300 |
| 2022/04/01 | 3,140 | 3,175 | 3,105 | 3,150 | +15 | +0.5% | 19,500 |
| 2022/03/31 | 3,140 | 3,195 | 3,135 | 3,135 | -20 | -0.6% | 28,300 |
| 2022/03/30 | 3,200 | 3,200 | 3,110 | 3,155 | -30 | -0.9% | 41,100 |
| 2022/03/29 | 3,195 | 3,200 | 3,150 | 3,185 | -20 | -0.6% | 41,300 |
| 2022/03/28 | 3,155 | 3,220 | 3,135 | 3,205 | +50 | +1.6% | 34,300 |
| 2022/03/25 | 3,125 | 3,185 | 3,125 | 3,155 | +30 | +1% | 23,900 |
| 2022/03/24 | 3,130 | 3,170 | 3,100 | 3,125 | -5 | -0.2% | 31,200 |
| 2022/03/23 | 3,085 | 3,145 | 3,065 | 3,130 | +85 | +2.8% | 32,900 |
| 2022/03/22 | 3,010 | 3,075 | 3,010 | 3,045 | +35 | +1.2% | 46,600 |
| 2022/03/18 | 2,934 | 3,015 | 2,922 | 3,010 | +95 | +3.3% | 59,500 |
| 2022/03/17 | 2,900 | 2,930 | 2,880 | 2,915 | +22 | +0.8% | 67,800 |
| 2022/03/16 | 2,898 | 2,916 | 2,882 | 2,893 | +13 | +0.5% | 62,500 |
| 2022/03/15 | 2,869 | 2,899 | 2,853 | 2,880 | +11 | +0.4% | 34,900 |
| 2022/03/14 | 2,850 | 2,899 | 2,850 | 2,869 | -14 | -0.5% | 31,700 |
| 2022/03/11 | 2,884 | 2,909 | 2,860 | 2,883 | -42 | -1.4% | 46,600 |
| 2022/03/10 | 2,929 | 2,940 | 2,885 | 2,925 | +64 | +2.2% | 76,400 |
| 2022/03/09 | 2,840 | 2,881 | 2,825 | 2,861 | +16 | +0.6% | 55,600 |
| 2022/03/08 | 2,853 | 2,902 | 2,823 | 2,845 | -51 | -1.8% | 65,300 |
| 2022/03/07 | 2,900 | 2,907 | 2,853 | 2,896 | -41 | -1.4% | 63,300 |
| 2022/03/04 | 2,921 | 2,982 | 2,902 | 2,937 | +12 | +0.4% | 75,100 |
| 2022/03/03 | 2,924 | 2,945 | 2,900 | 2,925 | +60 | +2.1% | 71,700 |
| 2022/03/02 | 2,918 | 2,944 | 2,865 | 2,865 | -77 | -2.6% | 41,600 |
| 2022/03/01 | 2,900 | 2,968 | 2,892 | 2,942 | +25 | +0.9% | 144,400 |
| 2022/02/28 | 2,944 | 2,944 | 2,892 | 2,917 | +17 | +0.6% | 99,900 |
| 2022/02/25 | 2,900 | 2,926 | 2,878 | 2,900 | +4 | +0.1% | 92,600 |
| 2022/02/24 | 2,900 | 2,910 | 2,845 | 2,896 | +12 | +0.4% | 81,700 |
| 2022/02/22 | 2,955 | 2,955 | 2,884 | 2,884 | -75 | -2.5% | 59,500 |
751～
800
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サワイＧＨＤ | 178,600円 | +5.9% | +24.5% | 3.08% | 11.85倍 | 1.12倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 429,000円 | +3.6% | +6.1% | 2.80% | 14.45倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.81倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 305,500円 | +7.9% | -3.3% | 2.62% | 8.50倍 | 0.88倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
